Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Irbesartan 300mg
Total, all-cause mortality	Placebo
Total, all-cause mortality	PS433540 200mg
Total, all-cause mortality	PS433540 400mg
Total, all-cause mortality	PS433540 800mg
Total, other adverse events	Irbesartan 300mg	19	58
Total, other adverse events	Placebo	20	59
Total, other adverse events	PS433540 200mg	10	58
Total, other adverse events	PS433540 400mg	25	58
Total, other adverse events	PS433540 800mg	17	28
Total, serious adverse events	Irbesartan 300mg	0	58
Total, serious adverse events	Placebo	0	59
Total, serious adverse events	PS433540 200mg	0	58
Total, serious adverse events	PS433540 400mg	1	58
Total, serious adverse events	PS433540 800mg	0	28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00635232/event-totals